Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

821
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
821
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

699
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
699
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

606
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
606
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.8K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

408
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
408
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Superhydrophobic polypyrene films to prevent Staphylococcus aureus and Pseudomonas aeruginosa biofilm adhesion on surfaces: high efficiency deciphered by fluorescence microscopy.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2018
Same author

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

3D shapes of aryl(dihydro)naphthothiophenes: a comprehensive and structural study.

Organic & biomolecular chemistry·2015
Same author

Understand, elucidate and rationalize the coordination mode of pyrimidylmethylamines: an intertwined study combining NMR and DFT methods.

Physical chemistry chemical physics : PCCP·2015
Same author

[The kidney of a gouty patient. Therapeutic conclusions].

Revue medicale de France·2014

Related Experiment Video

Updated: Mar 22, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.4K

Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.

P Netter, C Monot, M C Stalars

    European Journal of Drug Metabolism and Pharmacokinetics
    |April 1, 1984
    PubMed
    Summary

    In rheumatoid arthritis patients, salicylate protein binding decreases with lower serum albumin, especially in severe inflammation. Measuring free salicylate is crucial for effective treatment.

    More Related Videos

    Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
    04:50

    Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

    Published on: May 16, 2025

    1.3K
    Knee Arthrocentesis in Adults
    04:41

    Knee Arthrocentesis in Adults

    Published on: February 25, 2022

    10.2K

    Related Experiment Videos

    Last Updated: Mar 22, 2026

    An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
    07:37

    An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

    Published on: June 6, 2025

    1.4K
    Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
    04:50

    Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

    Published on: May 16, 2025

    1.3K
    Knee Arthrocentesis in Adults
    04:41

    Knee Arthrocentesis in Adults

    Published on: February 25, 2022

    10.2K

    Area of Science:

    • Pharmacology
    • Rheumatology
    • Biochemistry

    Background:

    • Salicylates are commonly used to manage rheumatoid arthritis.
    • Understanding salicylate binding is essential for optimizing therapeutic efficacy and safety.

    Purpose of the Study:

    • To investigate the relationship between serum albumin levels and salicylate binding in patients with rheumatoid arthritis.
    • To determine if changes in salicylate binding are linked to disease severity and inflammatory markers.

    Main Methods:

    • Equilibrium dialysis was used to separate free and bound salicylate fractions.
    • Spectrofluorimetry was employed for quantitative measurement of salicylates.
    • Study included 27 rheumatoid arthritis patients and 16 healthy controls.

    Main Results:

    • Salicylate protein binding decreased disproportionately with reduced serum albumin in rheumatoid arthritis patients.
    • This binding reduction correlated with the severity of the inflammatory syndrome.
    • Lowered saturation binding capacity per unit protein concentration was observed in patients with active disease, suggesting qualitative changes in albumin.

    Conclusions:

    • Serum albumin concentration significantly influences salicylate binding in rheumatoid arthritis.
    • Altered salicylate binding is associated with disease activity and inflammation severity.
    • Monitoring free salicylate concentrations is vital for effective management of inflammatory diseases.